At the time of writing, Medtronic Plc [MDT] stock is trading at $81.26, up 4.05%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MDT shares have gain 5.45% over the last week, with a monthly amount glided 0.27%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Medtronic Plc [NYSE: MDT] stock has seen the most recent analyst activity on May 30, 2024, when Goldman initiated its Sell rating and assigned the stock a price target of $83. Previously, Robert W. Baird started tracking the stock with Neutral rating on July 19, 2023, and set its price target to $90. On June 30, 2023, CL King initiated with a Buy rating and assigned a price target of $106 on the stock. Morgan Stanley upgraded its rating to a Overweight but stick to its price target of $104 on May 30, 2023. Wells Fargo upgraded its rating to a Overweight and raised its price target to $100 on April 24, 2023. UBS downgraded its rating to Sell for this stock on March 29, 2023, and downed its price target to $79. In a note dated January 09, 2023, RBC Capital Mkts downgraded an Sector Perform rating on this stock and revised its target price from $102 to $89.
For the past year, the stock price of Medtronic Plc fluctuated between $68.84 and $91.00. Currently, Wall Street analysts expect the stock to reach $109.35 within the next 12 months. Medtronic Plc [NYSE: MDT] shares were valued at $81.26 at the most recent close of the market. An investor can expect a potential return of 34.57% based on the average MDT price forecast.
Analyzing the MDT fundamentals
According to Medtronic Plc [NYSE:MDT], the company’s sales were 32.36B for trailing twelve months, which represents an 0.53% jump. Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.15%, and Net Profit Margin reading is 0.11%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.07 and Total Capital is 0.07. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.5.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 78.95 points at the first support level, and at 76.63 for the second support level. However, for the 1st resistance point, the stock is sitting at 82.57, and for the 2nd resistance point, it is at 83.87.
Ratios To Look Out For
It is important to note that Medtronic Plc [NYSE:MDT] has a current ratio of 2.03. Also, the Quick Ratio is 1.55, while the Cash Ratio stands at 0.12. Considering the valuation of this stock, the price to sales ratio is 3.22, the price to book ratio is 2.12 and price to earnings (TTM) ratio is 29.42.
Transactions by insiders
Recent insider trading involved Martha Geoffrey, Chairman and CEO, that happened on Jun 07 ’24 when 19113.0 shares were sold. EVP & President, Surgical OU, Marinaro Michael completed a deal on Apr 08 ’24 to sell 854.0 shares. Meanwhile, EVP & President Cardiovascular Salmon Sean sold 30695.0 shares on Feb 21 ’24.
